Phreesia Income from Continuous Operations 2019-2025 | PHR

Phreesia income from continuous operations from 2019 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Phreesia Annual Income from Continuous Operations
(Millions of US $)
2025 $-59
2024 $-137
2023 $-176
2022 $-118
2021 $-27
2020 $-20
2019 $-15
2018 $-18
Phreesia Quarterly Income from Continuous Operations
(Millions of US $)
2025-04-30 $-4
2025-01-31 $-6
2024-10-31 $-14
2024-07-31 $-18
2024-04-30 $-20
2024-01-31 $-31
2023-10-31 $-32
2023-07-31 $-37
2023-04-30 $-38
2023-01-31 $-38
2022-10-31 $-40
2022-07-31 $-47
2022-04-30 $-51
2022-01-31 $-46
2021-10-31 $-36
2021-07-31 $-24
2021-04-30 $-11
2021-01-31 $-8
2020-10-31 $-7
2020-07-31 $-6
2020-04-30 $-6
2020-01-31 $-4
2019-10-31 $-2
2019-07-31 $-7
2019-04-30 $-7
2019-01-31
2018-10-31 $-4
2018-07-31 $-3
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.591B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.644B 58.07
Doximity (DOCS) United States $11.655B 53.96
Hims & Hers Health (HIMS) United States $11.295B 117.35
Tempus AI (TEM) United States $9.675B 0.00
IRhythm Technologies (IRTC) United States $4.275B 0.00
Inspire Medical Systems (INSP) United States $3.775B 58.99
Hinge Health (HNGE) United States $3.572B 0.00
Privia Health (PRVA) United States $2.516B 172.00
Enovis (ENOV) United States $1.765B 9.84
Clover Health Investments (CLOV) United States $1.517B 0.00
10x Genomics (TXG) United States $1.505B 0.00
Schrodinger (SDGR) United States $1.495B 0.00
Azenta (AZTA) United States $1.461B 67.89
Evolent Health (EVH) United States $1.335B 113.70
Omnicell (OMCL) United States $1.276B 22.51
Claritev (CTEV) United States $0.717B 0.00
Fulgent Genetics (FLGT) United States $0.550B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Butterfly Network (BFLY) United States $0.435B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.321B 713.00
Outset Medical (OM) United States $0.320B 0.00
Nyxoah SA (NYXH) Belgium $0.270B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.213B 0.00
Zepp Health (ZEPP) Netherlands $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
American Well (AMWL) United States $0.125B 0.00
EUDA Health Holdings (EUDA) Singapore $0.120B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00